: Speakers

Speakers

07 - 08 February 2022 | San Diego, USA
+ Digital Day: 09 February 2022 | Online

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for Immuno US: In-Person 2022

Andrew Allen
Co-Founder, President and Chief Executive Officer
Gritstone Oncology
Antonio Santidrian
Vice President Research & Development and Translational Oncology
Calidi Biotherapeutics
Aude-Helene Capietto
Senior Scientific Researcher, Cancer Immunology Department
Genentech
Bonnie Hammer
Vice President, Biologics Development
Invenra
Chrystal Paulos
Director of Translational Research, Melanoma & Cutaneous Malignancies
Emory University
Dan Passeri
President & CEO
Cue Biopharma
Dave Hoon
Professor, Director
St.John's Cancer Institute
Dimitrios Mathios
Neurosurgery Chief Resident
Johns Hopkins University, School of Medicine
Ezinneka Imoh
Manager, Scientific Communications, Global Medical Affairs Oncology & CAR T Cell Therapy
Karyopharm Therapeutics Inc.
Hua Eleanor Yu
Billy and Audrey Wilder Endowed Professor
City of Hope Comprehensive Cancer Center
Jadwiga Bienkowska
Sr. Director, Computational Biology ORD
Pfizer
Jeffrey Skolnik
Vice President, Clinical Development
Inovio Pharmaceuticals
Joanne Tan
Director
Nkarta Therapeutics
John Lu
CSO
HebeCell Corporation
John Rossi
Head of Translational Medicine, SVP Research
Cero Therapeutics
Kevin Gergich
Executive Director, Oncology Clinical Operations
MSD
Koustubh Ranade
Head of Translational Medicine at Immunocore
Immunocore
Mark Salvati
Global Product General Manager, Amgen Oncology Early Development
Amgen
Matthew Kunicki
Senior Scientist
Pfizer
Michael Groaning
Global Medical Affairs Lead
Amgen
Mingchao Kang
Group Lead, Head of Technology Platform
Ambrx
Nadia Hassounah
Principal Scientist, Translational Immuno-Oncology
Novartis
Nathalie Fiaschi
Director, Oncology & Angiogenesis
Regeneron
Paul Moore
Vice President, Cell Biology and Immunity
Macrogenics
Philip M Arlen
President and CEO
Precision Biologics, Inc
Pravin Kaumaya
Professor and Director Vaccine Development
The Ohio State University
Russell LaMontagne
President and CEO
Boston Immune Technologies & Therapeutics
Sonia Iyer
Associate Director Translational Immuno-Oncology, Oncology R&D
AstraZeneca
Tauseef R. Butt
President and Chief Executive Officer
Progenra
Youg Thaker
Senior Scientist
Sorrento Therapeutics

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.